Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Deltagarna i denna del av studien hade inte diabetes
In controlled trials, pancreatitis rates in GLP-1 groups ranged from 0.1% to 1.2% , with placebo groups reporting similar numbers
Contact your healthcare provider if you experience minimal improvement after reaching maintenance dose for 12-16 weeks, including persistently elevated blood glucose or lack of at least 5% body weight reduction
Clinical studies show patients treated with GLP-1s experienced an average weight loss of 14.9-20.9% of their total body weight after 68-72 weeks
